Proveca Pharma

Proveca Pharma is a private, commercial-stage biopharmaceutical company dedicated to improving paediatric care through the development and commercialization of licensed, child-friendly medicines. Founded in 2011 and headquartered in Manchester, UK, the company targets chronic conditions in neurology and cardiology, transforming existing active ingredients into approved, palatable formulations. It operates across Europe, leveraging a lean business model of in-licensing and strategic development to bring essential treatments to a historically underserved market.

Specialized paediatric drug development platform focusing on reformulating known APIs into age-appropriate, licensed medicines. Expertise includes paediatric formulation science, regulatory strategy for paediatric indications (PIPs), and clinical trial design for paediatric populations.

Competes against off-label use of adult formulations and compounded pharmacy products. Potential competition from originator companies pursuing paediatric indications and generic manufacturers developing paediatric formulations post-patent expiry. Niche focus provides differentiation from broad pharma companies.